globenewswire

Intra-Cellular Therapies Prices $114 Million Public Offering of Common Stock

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 05 March 2015 15:00

NEW YORK, March 5, 2015 (GLOBE NEWSWIRE)

Read more...
 

Tekmira Conference Call and dortalaw.com/seroquel-xr/ nolvadex gynecomastia Webcast Advisory: Corporate Update and online generic cialis 50 mg www.stepspa.com/flagyl-online/ Full Year 2014 Financial Results

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 05 March 2015 13:30

VANCOUVER, British Columbia--Tekmira Pharmaceuticals Corporation (Nasdaq:TKMR), a biopharmaceutical company dedicated to discovering, developing and canadian healthcare viagra commercializing a cure for patients suffering from chronic hepatitis B infection (HBV), announced that it will hold a conference call and webcast on Thursday, March 12, 2015 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) to provide a corporate update and report on its financial results for the fourth quarter and viagra tablet viagra usa year ended December 31, 2014.

Read more...
 

Colon Cancer Awareness Month shines BLUE lights on the country.

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 05 March 2015 10:45

MINNEAPOLIS--The Colon Cancer Coalition kicked-off a jam-packed Colon Cancer Awareness Month by basking in the blue lights of the 35W Bridge in Minneapolis. But to the colon cancer community, the color blue on such a prominent landmark means more.

Read more...
 

Cellular Dynamics International Reports Fourth Quarter and Fiscal Year 2014 Financial Results

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 05 March 2015 10:30

MADISON, Wis.--Cellular Dynamics International, Inc. (CDI) (Nasdaq:ICEL), a developer and 6thnde.com/prednisone-online-overnight/ producer of fully functioning human cells in industrial quantities to precise specifications, today reported financial results for the fourth quarter and for the fiscal year ended December 31, 2014.

Read more...
 

Galena Biopharma Reports Fourth Quarter and Year End 2014 Financial Results

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 05 March 2015 10:10

PORTLAND, Ore.--Galena Biopharma, Inc. (Nasdaq:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology therapeutics that address major medical needs across the full spectrum of cancer care, today reported its financial results for the quarter and year ended December 31, 2014 and provided a business update.

Read more...
 

XOMA Will Present XOMA 358 Phase 1 Data at ENDO 2015

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 05 March 2015 10:05

BERKELEY, Calif.--XOMA Corporation (Nasdaq:XOMA), a leader in the discovery and viagra soft development of therapeutic antibodies, announced today the results from its Phase 1 first-in-human study of XOMA 358, an allosteric modulating monoclonal antibody that binds to insulin receptors and cheap cialis online canadian pharmacy attenuates insulin action, will be presented at the Endocrine Society's 97th Annual Meeting, taking place from March 5-8, 2015, in San Diego, California.

Read more...
 

Prothena Reports Fourth Quarter and Full Year 2014 Financial Results and buy cytotec Provides 2015 Financial Guidance and cialis for sale R&D Update

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 05 March 2015 10:05

DUBLIN, Ireland--Prothena Corporation plc (Nasdaq:PRTA), a late-stage clinical biotechnology company focused on the discovery, development and discount canadian pharmacy commercialization of novel protein immunotherapy programs, today reported financial results for the fourth quarter and full year ended December 31, 2014 and provided 2015 financial guidance and an update on its lead programs.

Read more...
 

Fibrocell Science to Report Fourth Quarter 2014 and Full Year 2014 Financial and Operating Results, and Host Conference Call and Webcast on March 13, 2015

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 05 March 2015 10:05

EXTON, Pa.--Fibrocell Science, Inc. (Nasdaq:FCSC), an autologous cell therapy company focused on developing first-in-class treatments for rare and serious skin and connective tissue diseases with high unmet medical needs, today announced that it will report fourth quarter and full year 2014 financial and operating results on March 13, 2015.

Read more...
 

Five Prime Therapeutics to Present at the Barclays Global Healthcare Conference

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 05 March 2015 10:05

SOUTH SAN FRANCISCO, Calif.--Five Prime Therapeutics, Inc. (Nasdaq:FPRX) (Five Prime), a clinical-stage biotechnology company focused on discovering and developing novel protein therapeutics for cancer and inflammatory diseases, today announced that Julie Hambleton, M.D., Chief Medical Officer, will present at the Barclays Global Healthcare Conference on Thursday, March 12, 2015 at 1:05 PM Eastern Daylight Time.

Read more...
 

Calithera Biosciences Gains Exclusive, Worldwide License to TransTech Pharma's Hexokinase II Inhibitor Program

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 05 March 2015 10:02

SOUTH SAN FRANCISCO, Calif.--Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer, announced today an exclusive global license agreement with TransTech Pharma, a clinical stage pharmaceutical company, granting Calithera exclusive world-wide rights to research, develop and commercialize TransTech's portfolio of hexokinase II inhibitors.

Read more...
 

The Cooper Companies Announces First Quarter 2015 Results

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 05 March 2015 10:01

PLEASANTON, Calif.--The Cooper Companies, Inc. (NYSE:COO) today announced financial results for the fiscal first quarter ended January 31, 2015.

Read more...
 

Vital Therapies Announces Fourth Quarter and Full Year 2014 Financial Results Conference Call With Webcast

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 05 March 2015 10:01

SAN DIEGO, March 5, 2015 (GLOBE NEWSWIRE)

Read more...
 

Fate Therapeutics to Webcast Conference Call Reporting Fourth Quarter and Full Year 2014 Financial Results on March 12, 2015

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 05 March 2015 10:01

SAN DIEGO, March 5, 2015 (GLOBE NEWSWIRE)

Read more...
 

MRI Interventions Reports 2014 Financial Results

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 05 March 2015 10:00

IRVINE, Calif., March 5, 2015 (GLOBE NEWSWIRE)

Read more...
 

Department of Energy "Better Building Challenge" Proposed for New Jersey Senior Care Facilities

Print E-mail
By GLOBE NEWSWIRE   
Thursday, 05 March 2015 07:15

PRINCETON, N.J., March 5, 2015 (GLOBE NEWSWIRE)

Read more...
 
<< Start < Prev 1 3 4 5 6 7 8 9 10 > End >>

Page 1 of 659

Newsletter